InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by BINGHAM KATE, Director. Insider active across 1 company, notably BICYCLE THERAPEUTICS plc. Cumulatively, 4 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €67k. History available since 13 July 2021. The latest transaction was disclosed on 13 July 2021 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
588 shares@ US$33.5025.0% of flowOrdinary SharesSEC:0000899243-21-028984
588 shares@ US$33.500.0034% mcap25.0% of flowOrdinary SharesSEC:0000899243-21-028984:0
588 shares@ US$33.5025.0% of flowOrdinary SharesSEC:0000899243-21-028546
588 shares@ US$33.500.0034% mcap25.0% of flowOrdinary SharesSEC:0000899243-21-028546:0
4 of 4 declarations
About BINGHAM KATE
Kate Bingham serves as a Director for Bicycle Therapeutics plc. She brings expertise in biotechnology and product development to the board. Her experience in the healthcare sector enables her to contribute to the company's strategy and guide key decisions.
